159 related articles for article (PubMed ID: 19473053)
1. Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.
Hlobilkova A; Ehrmann J; Knizetova P; Krejci V; Kalita O; Kolar Z
Neoplasma; 2009; 56(4):284-90. PubMed ID: 19473053
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways.
Mani N; Khaibullina A; Krum JM; Rosenstein JM
Exp Neurol; 2005 Apr; 192(2):394-406. PubMed ID: 15755557
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.
Inan S; Vatansever S; Celik-Ozenci C; Sanci M; Dicle N; Demir R
Histol Histopathol; 2006 Oct; 21(10):1055-64. PubMed ID: 16835828
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.
Yao Y; Kubota T; Sato K; Kitai R; Takeuchi H; Arishima H
Acta Neurochir (Wien); 2001; 143(2):159-66. PubMed ID: 11459088
[TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells.
Xiang F; Tanaka J; Takahashi J; Fukuda T
Brain Tumor Pathol; 2001; 18(2):67-71. PubMed ID: 11908876
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor enhances migration of astroglial cells in subventricular zone neurosphere cultures.
Mani N; Khaibullina A; Krum JM; Rosenstein JM
J Neurosci Res; 2010 Feb; 88(2):248-57. PubMed ID: 19705456
[TBL] [Abstract][Full Text] [Related]
10. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues.
Pallares J; Rojo F; Iriarte J; Morote J; Armadans LI; de Torres I
Histol Histopathol; 2006 Aug; 21(8):857-65. PubMed ID: 16691538
[TBL] [Abstract][Full Text] [Related]
11. VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma.
Talvensaari-Mattila A; Soini Y; Santala M
Tumour Biol; 2005; 26(2):81-7. PubMed ID: 15867479
[TBL] [Abstract][Full Text] [Related]
12. Expression of VEGFR3 in glioma endothelium correlates with tumor grade.
Grau SJ; Trillsch F; Herms J; Thon N; Nelson PJ; Tonn JC; Goldbrunner R
J Neurooncol; 2007 Apr; 82(2):141-50. PubMed ID: 17115285
[TBL] [Abstract][Full Text] [Related]
13. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
[TBL] [Abstract][Full Text] [Related]
16. Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma.
Ma C; Li Y; Zhang X; Zhao G; Xu H
J Int Med Res; 2014 Feb; 42(1):198-204. PubMed ID: 24398760
[TBL] [Abstract][Full Text] [Related]
17. Nestin expression in astrocytic tumors delineates tumor infiltration.
Kitai R; Horita R; Sato K; Yoshida K; Arishima H; Higashino Y; Hashimoto N; Takeuchi H; Kubota T; Kikuta K
Brain Tumor Pathol; 2010 Apr; 27(1):17-21. PubMed ID: 20425043
[TBL] [Abstract][Full Text] [Related]
18. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
19. Astrocytoma grade IV (glioblastoma multiforme) displays 3 subtypes with unique expression profiles of intermediate filament proteins.
Skalli O; Wilhelmsson U; Orndahl C; Fekete B; Malmgren K; Rydenhag B; Pekny M
Hum Pathol; 2013 Oct; 44(10):2081-8. PubMed ID: 23791210
[TBL] [Abstract][Full Text] [Related]
20. Loss of inhibitor of growth (ING-4) is implicated in the pathogenesis and progression of human astrocytomas.
Klironomos G; Bravou V; Papachristou DJ; Gatzounis G; Varakis J; Parassi E; Repanti M; Papadaki H
Brain Pathol; 2010 Mar; 20(2):490-7. PubMed ID: 19775294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]